ImmunityBio Ownership | Who Owns ImmunityBio?
ImmunityBio Ownership Summary
ImmunityBio is owned by 6.47% institutional investors, 62.48% insiders, and 31.05% retail investors. Vanguard group is the largest institutional shareholder, holding 3.46% of IBRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.10% of its assets in ImmunityBio shares.
IBRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ImmunityBio | 6.47% | 62.48% | 31.05% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 32.78M | 3.46% | $64.90M |
| Blackrock funding, inc. /de | 26.35M | 2.86% | $202.08M |
| State street | 17.71M | 1.93% | $135.82M |
| Blackrock | 11.42M | 1.70% | $72.19M |
| D. e. shaw | 12.57M | 1.37% | $96.42M |
| Geode capital management | 8.03M | 0.87% | $61.62M |
| Heights capital management | 6.57M | 0.74% | $16.15M |
| Two sigma investments, lp | 4.39M | 0.48% | $33.64M |
| Morgan stanley | 4.02M | 0.44% | $30.82M |
| Hrt financial lp | 3.93M | 0.43% | $30.11M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Heights capital management | 6.57M | 4.43% | $16.15M |
| Kercheville advisors | 643.14K | 1.58% | $4.93M |
| Mfg wealth management | 175.35K | 1.12% | $1.34M |
| Nia impact advisors | 268.80K | 0.92% | $2.06M |
| Virtus investment advisers | 357.75K | 0.76% | $2.74M |
| Winning points advisors | 722.37K | 0.54% | $509.00K |
| Allen inc /ny | 687.57K | 0.52% | $5.27M |
| Carr financial group | 251.63K | 0.51% | $1.93M |
| Sheets smith wealth management | 552.02K | 0.48% | $4.23M |
| Clearwater capital advisors | 717.52K | 0.44% | $5.50M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| D. e. shaw | 12.57M | 0.06% | 12.57M |
| Heights capital management | 6.57M | 4.43% | 6.57M |
| Vanguard group | 32.78M | 0.00% | 5.12M |
| Hrt financial lp | 3.93M | 0.08% | 3.93M |
| Voloridge investment management | 2.93M | 0.09% | 2.93M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jane street group | 704.23K | 0.00% | -13.52M |
| Armistice capital | - | - | -7.76M |
| Cormorant asset management, lp | - | - | -3.00M |
| Alphacore capital | 14.05K | 0.00% | -2.99M |
| Goldman sachs group | 3.24M | 0.00% | -2.92M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| D. e. shaw | 12.57M | 0.06% | 12.57M | $96.42M |
| Heights capital management | 6.57M | 4.43% | 6.57M | $16.15M |
| Hrt financial lp | 3.93M | 0.08% | 3.93M | $30.11M |
| Voloridge investment management | 2.93M | 0.09% | 2.93M | $22.45M |
| Vanguard fiduciary trust | 2.12M | 0.00% | 2.12M | $16.28M |
Sold Out
| Holder | Change |
|---|---|
| Dinuzzo private wealth | -3.00 |
| Hfm investment advisors | -4.00 |
| Investors research | -15.00 |
| Financial gravity asset management | -17.00 |
| True wealth design | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 226 | -20.14% | 59,534,423 | -64.77% | 6 | 2.03% | 166 | 16.90% | 29 | -54.69% |
| Dec 31, 2025 | 199 | -27.11% | 140,741,730 | -1.64% | 14 | 5.73% | 97 | -28.68% | 42 | -27.59% |
| Sep 30, 2025 | 181 | -26.42% | 94,869,384 | -19.91% | 10 | 6.01% | 85 | -45.51% | 42 | 23.53% |
| Jun 30, 2025 | 254 | 15.45% | 123,819,651 | 52.36% | 13 | 15.36% | 159 | 32.50% | 37 | -13.95% |
| Mar 31, 2025 | 220 | 4.27% | 81,251,228 | -1.72% | 9 | 6.75% | 119 | 6.25% | 44 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 11.48M | 1.10% | 131.83K |
| State Street® SPDR® S&P® Biotech ETF | 11.42M | 1.09% | -112.97K |
| Vanguard Small Cap Index | 8.29M | 0.79% | -6.33K |
| Vanguard US Total Market Shares ETF | 5.72M | 0.67% | 1.43M |
| iShares Russell 2000 ETF | 6.93M | 0.66% | 58.42K |
| Vanguard Small Cap Growth Index Inv | 4.67M | 0.45% | 25.15K |
| Vanguard Institutional Extnd Mkt Idx Tr | 3.45M | 0.33% | 36.89K |
| SPDR® S&P Biotech ETF | 3.08M | 0.33% | 6.87K |
| Fidelity Small Cap Index | 2.89M | 0.28% | 31.52K |
| iShares Biotechnology ETF | 2.56M | 0.24% | 37.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 04, 2026 | Simon Barry J. | - | Sell | $165.31K |
| Feb 24, 2026 | Simon Barry J. | - | Sell | $900.79K |
| Feb 23, 2026 | Selecky Christobel | - | Sell | $250.00K |
| Feb 23, 2026 | Simon Barry J. | - | Sell | $1.69M |
| Feb 20, 2026 | Simon Barry J. | - | Sell | $92.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 8 |
| 2025 Q4 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
IBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools